Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
about
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.Five myths about variable selection.Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
P2860
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cytomegalovirus prevention str ...... nto current clinical practice.
@en
type
label
Cytomegalovirus prevention str ...... nto current clinical practice.
@en
prefLabel
Cytomegalovirus prevention str ...... nto current clinical practice.
@en
P2093
P2860
P356
P1476
Cytomegalovirus prevention str ...... nto current clinical practice.
@en
P2093
Alicia Mendiluce
Antonio Franco-Esteve
Carlos Gómez-Alamillo
David Navarro
Domingo Hernández
Enrique Luna-Huerta
Ernesto Gómez-Huertas
Esther González
Francesc J Moreso
Frederic Cofan
P2860
P304
P356
10.1111/TRI.12586
P577
2015-04-23T00:00:00Z